Ellen T. Lance

412 total citations
7 papers, 326 citations indexed

About

Ellen T. Lance is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Hematology. According to data from OpenAlex, Ellen T. Lance has authored 7 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cardiology and Cardiovascular Medicine, 6 papers in Surgery and 2 papers in Hematology. Recurrent topics in Ellen T. Lance's work include Antiplatelet Therapy and Cardiovascular Diseases (6 papers), Acute Myocardial Infarction Research (4 papers) and Coronary Interventions and Diagnostics (4 papers). Ellen T. Lance is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (6 papers), Acute Myocardial Infarction Research (4 papers) and Coronary Interventions and Diagnostics (4 papers). Ellen T. Lance collaborates with scholars based in United States. Ellen T. Lance's co-authors include Robert E. Jordan, Mary Ann Mascelli, Harlan F. Weisman, Lakshmi Damaraju, Carrie Wagner, Seth J. Worley, Neal S. Kleiman, Kelly Maresh, Anthony J. Fischer and Bart Frederick and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and American Heart Journal.

In The Last Decade

Ellen T. Lance

7 papers receiving 296 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ellen T. Lance United States 4 261 195 86 77 24 7 326
Rene van Dijk Canada 5 231 0.9× 188 1.0× 46 0.5× 110 1.4× 14 0.6× 6 312
Michael Schleef Germany 3 224 0.9× 179 0.9× 78 0.9× 64 0.8× 17 0.7× 3 318
Clyde R. Meckel United States 4 336 1.3× 226 1.2× 43 0.5× 217 2.8× 13 0.5× 6 395
V. Kötter Germany 5 237 0.9× 137 0.7× 44 0.5× 118 1.5× 4 0.2× 6 284
Sabino R. Torre United States 7 192 0.7× 201 1.0× 26 0.3× 33 0.4× 29 1.2× 13 275
Sarah Just Australia 11 41 0.2× 60 0.3× 232 2.7× 39 0.5× 26 1.1× 15 286
Kent Chapman Australia 10 46 0.2× 71 0.4× 189 2.2× 39 0.5× 30 1.3× 18 256
Slobodan Antov North Macedonia 8 60 0.2× 53 0.3× 38 0.4× 38 0.5× 68 2.8× 16 169
Birgit Jurlander Denmark 7 156 0.6× 78 0.4× 134 1.6× 14 0.2× 16 0.7× 14 349
Fernando Luiz de Melo Bernardi Brazil 8 129 0.5× 32 0.2× 146 1.7× 54 0.7× 54 2.3× 19 278

Countries citing papers authored by Ellen T. Lance

Since Specialization
Citations

This map shows the geographic impact of Ellen T. Lance's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen T. Lance with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen T. Lance more than expected).

Fields of papers citing papers by Ellen T. Lance

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ellen T. Lance. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen T. Lance. The network helps show where Ellen T. Lance may publish in the future.

Co-authorship network of co-authors of Ellen T. Lance

This figure shows the co-authorship network connecting the top 25 collaborators of Ellen T. Lance. A scholar is included among the top collaborators of Ellen T. Lance based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ellen T. Lance. Ellen T. Lance is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Kleiman, Neal S., Robert E. Jordan, Ellen T. Lance, et al.. (2000). Ticlopidine Enhances the Platelet Inhibitory Capacity of Abciximab In Vitro. Journal of Thrombosis and Thrombolysis. 9(1). 29–36. 5 indexed citations
2.
Kleiman, Neal S., Kelly Maresh, Rebecca J. Taylor, et al.. (2000). Abciximab, ticlopidine, and concomitant abciximab-ticlopidine therapy: Ex vivo platelet aggregation inhibition profiles in patients undergoing percutaneous coronary interventions. American Heart Journal. 140(3). 492–501. 10 indexed citations
3.
Mascelli, Mary Ann, Stanley J. Marciniak, Ellen T. Lance, & Robert E. Jordan. (1998). Abciximab inhibits release of platelet granule constituents. Journal of the American College of Cardiology. 31. 24–25. 2 indexed citations
4.
Kleiman, Neil, et al.. (1998). Synergy of abciximab and ticiopidine in patients undergoing intracoronary stenting. Journal of the American College of Cardiology. 31. 238–238. 1 indexed citations
5.
Mascelli, Mary Ann, Ellen T. Lance, Lakshmi Damaraju, et al.. (1998). Pharmacodynamic Profile of Short-term Abciximab Treatment Demonstrates Prolonged Platelet Inhibition With Gradual Recovery From GP IIb/IIIa Receptor Blockade. Circulation. 97(17). 1680–1688. 231 indexed citations
7.
Mascelli, Mary Ann, et al.. (1996). Rapid assessment of platelet inhibition using a modified whole blood aggregometer (aggrestat™) in PTCA patients receiving ReoPro™. Journal of the American College of Cardiology. 27(2). 361–361. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026